← Open Payments lookup

SARA BACHANI: Open Payments

NPI 1407230378 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$597 in 34 payments from 10 companies in 2025. Trend: 2023 $40 · 2024 $259 · 2025 $597

Food & beverage: $589Education: $8
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.13$169
E.R. Squibb & Sons, L.L.C.7$119
Corium, LLC4$98
Otsuka America Pharmaceutical, Inc.3$66
Janssen Pharmaceuticals, Inc2$46
Vanda Pharmaceuticals Inc.1$30
ABBVIE INC.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15
HARMONY BIOSCIENCES LLC1$14
Teva Pharmaceuticals USA, Inc.1$14

Products named: Qelbree, COBENFY, Azstarys, REXULTI, SPRAVATO, FANAPT, VRAYLAR, ABILIFY ASIMTUFII.

Industry payments across PA — which companies pay providers there.